The 20 Best Upper Tract Urothelial Carcinoma (UTUC) Doctors Near Me in Arlington, VA

Dr. Thomas W. Jarrett has an expertise in minimally invasive surgery, including laparoscopic, robotic, ureteroscopic, percutaneous and image-guided therapies. Specifically, he has an expertise in percutaneous renal surgery, laparoscopic partial and radical nephrectomy, kidney stones, urinary tract reconstruction and kidney cancer. Dr. Jarrett earned his medical degree from Emory University School of Medicine, where he also completed his internship. He completed a residency in urology at New York Hospital, followed by a visiting fellowship in urology and ultrasonography in Salzburg, Austria. Dr. Jarrett completed his fellowship in endo-urology at Long Island Jewish Medical Center. He has previously served as the chief of the division of endourology and laparoscopy at the Johns Hopkins Hospital and the chief of the division of urology at Johns Hopkins Bayview Medical Center. Dr. Jarrett has been named a Top MD by Consumers’ Checkbook Magazine and a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly. He has also been named a Super Doctor by the Washington Post. Dr. Jarrett is a member of the American Urological Association, the Society of Urologic Oncology and the Endourological Society. Dr. Jarrett has contributed to various publications and presentations on urology, earning him first prize in the World Congress of Endourology essay contest and the Faculty Research Award at Long Island Jewish Medical Center. He has editorial appointments at the Journal of Endourology and the Journal of Laparoendoscopic and Advanced Surgical Techniques. Dr. Jarrett is rated as an Advanced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Ureterocele, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Nephrectomy, and Ureteroscopy.

Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). Her top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, Pancreaticoduodenectomy, and Gastrostomy.

Andrew Akman, MD, MBA a native of Washington, DC, currently practices at Suburban Hospital, Sibley Hospital, and Johns Hopkins Hospital. Dr. Akman performs a variety of minimally invasive procedures. He has specific interest in complex IVC filter removals, interventional oncology, pulmonary embolism, and prostate artery embolization. Dr. Akman is an expert in complex IVC filter retrieval and IVC filter related complications. In addition to standard IVC filter retrievals, he removes devices that are severely tilted, embedded, or fractured, as well as those designated as permanent devices. He serves as an adviser to other physicians on complex techniques including laser sheath and forceps assisted retrieval. Within interventional oncology, Dr. Akman performs thermal ablation of lung, liver, and kidney tumors. He performs chemoembolization and radioembolization (Yttrium-90) on primary liver cancer and metastatic liver disease. Dr. Akman also performs prostate artery embolization, an emerging minimally invasive technique for treating urinary symptoms associated with prostate enlargement. Dr. Akman prides himself on building strong relationships with his patients and practicing patient-centered medicine. Videos Andrew Akman, M.D., Interventional Radiologist Recent News Articles and Media Coverage Honoring a Life By Helping Others, Johns Hopkins Medicine, (July 20, 2022). Dr. Akman is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Ascites, Ureterocele, Familial Pancreatic Cancer, Gastrostomy, and Liver Embolization.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Dr. Ramez I. Andrawis is a urologist affiliated with Sibley Memorial Hospital and George Washington University Hospital, where he is an assistant professor of urology and the director of the Urology Lab. He practices out of GW Medical Faculty Associates in Washington, D.C. Dr. Andrawis has an expertise in female urology, benign prostatic hyperplasia, urinary incontinence and reconstructive surgery. Dr. Andrawis earned his undergraduate and medical degree from the University of Cairo in Egypt, where he went on to complete a residency in urology. Dr. Andrawis also completed a residency in urology at the Royal College of Surgeons in Ireland, a general surgery residency at New Britain General Hospital and a urology residency at George Washington University Hospital. Dr. Andrawis has been named a Top Doctor in the Washington, D.C. and Washington-Baltimore areas by Castle Connolly. Dr. Andrawis has contributed to numerous publications on urology. Dr. Andrawis is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Bilateral Hydronephrosis, and Ureteroscopy.

Michael Whalen is an Oncologist in Washington, Washington, D.c.. Dr. Whalen has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Bladder Cancer, Traumatic Brain Injury, Urothelial Cancer, Cystectomy, and Nephrectomy.

John Feigert is a Hematologist and an Oncologist in Arlington, Virginia. Dr. Feigert is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, Multiple Myeloma, and Chronic Lymphocytic Leukemia (CLL).

Keeran Sampat is a Hematologist and an Oncologist in Arlington, Virginia. Dr. Sampat is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast.

Ross Krasnow is a Urologist in Washington, Washington, D.c.. Dr. Krasnow has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Cystectomy.

Dr. Bhagat is an interventional radiologist serving as the director of Vascular and Interventional Radiology of the National Capital Region. His primary areas of clinical expertise are interventional oncology (chemoembolization, radioembolization, and ablation), women's interventions, and vascular interventions (venous and arterial). Dr. Bhagat sees patients at both Suburban Hospital and Sibley Memorial Hospital. His research interests include interventional oncology, especially device development and software assistance for complex procedures. Dr. Bhagat successfully completed his Vascular and Interventional Radiology fellowship at the University of California, San Francisco in 2009. He joined the staff as an Assistant Professor of Radiology and Surgery at the Johns Hopkins University School of Medicine. While there, he authored more than 5 book chapters and 20 peer-reviewed manuscripts as well as giving many lectures at national and international meetings. In his second year at Johns Hopkins, he received a NIH R01 grant. Videos Nikhil Bhagat, M.D. Dr. Bhagat is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Ascites, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Liver Embolization, and Gastrostomy.

Micael Lopez is a Hematologist in Washington, Washington, D.c.. Dr. Lopez is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Ovarian Cancer, Malignant Mixed Mullerian Tumor, Cervical Cancer, and Virilizing Ovarian Tumor.

Nancy Dawson is an Internal Medicine provider in Washington, Washington, D.c.. Dr. Dawson is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Prostatectomy.

George Philips is an Oncologist in Washington, Washington, D.c.. Dr. Philips is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer.

Gaurav Bandi is a Urologist in Washington, Washington, D.c.. Dr. Bandi is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Prostatectomy, and Ureteroscopy.

John Lynch is a Urologist in Washington, Washington, D.c.. Dr. Lynch is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Prostatectomy, and Nephrectomy.

Keith John is a Urologist in Washington, Washington, D.c.. Dr. John is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Wilms Tumor, Familial Wilms Tumor 2, Clear Cell Sarcoma, Reconstructive Urology Surgery, and Vasectomy.

Harold Frazier is a Urologist in Washington, Washington, D.c.. Dr. Frazier is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Reconstructive Urology Surgery, and Hernia Surgery.

Robert Mordkin is a Urologist in Arlington, Virginia. Dr. Mordkin is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Andrew Joel is a Urologist in Arlington, Virginia. Dr. Joel is rated as an Experienced provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.